https://caseinkinasesignals.co....m/index.php/managing
We formerly reported a solution to determine compounds that suppress aggregation, based on screening making use of multiple terminal deletion mutants. We currently provide a strategy to determine the aggregation contact sites of proteins, using such solubilizing substances, to develop monodispersed mutants. We applied this plan towards the chemokine receptor-binding domain (CRBD) of FROUNT, which binds into the